NL
IBB icon

NWAM LLC’s iShares Biotechnology ETF IBB Stock Holding History

NWAM LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Sell
1,408
-147
-9% -$25.1K 0.01% 560
2025
Q4 		$272K Sell
1,555
-89
-5% -$14.5K 0.02% 524
2025
Q3 		$255K Hold
1,644
– – 0.01% 558
2025
Q2 		$217K Buy
+1,644
New +$202K 0.01% 577
2025
Q1 		– Sell
-1,774
Closed -$235K – 546
2024
Q4 		$235K Sell
1,774
-142
-7% -$20K 0.01% 539
2024
Q3 		$279K Buy
+1,916
New +$277K 0.02% 513
2024
Q2 		– Sell
-3,642
Closed -$490K – 316
2024
Q1 		$490K Sell
3,642
-3,406
-48% -$465K 0.04% 341
2023
Q4 		$958K Sell
7,048
-2,395
-25% -$292K 0.08% 237
2023
Q3 		$1.15M Sell
9,443
-41,404
-81% -$5.27M 0.12% 173
2023
Q2 		$6.46M Buy
50,847
+5,101
+11% +$663K 0.53% 34
2023
Q1 		$5.91M Sell
45,746
-5,089
-10% -$666K 0.6% 28
2022
Q4 		$6.67M Buy
50,835
+36,606
+257% +$4.73M 0.59% 27
2022
Q3 		$1.66M Buy
14,229
+584
+4% +$72.5K 0.16% 135
2022
Q2 		$1.64M Sell
13,645
-13
-0.1% -$1.54K 0.15% 136
2022
Q1 		$1.78M Buy
13,658
+6,647
+95% +$866K 0.14% 150
2021
Q4 		$1.07M Sell
7,011
-258
-4% -$39.9K 0.08% 220
2021
Q3 		$1.18M Sell
7,269
-290
-4% -$48.8K 0.11% 201
2021
Q2 		$1.24M Sell
7,559
-1,788
-19% -$275K 0.11% 180
2021
Q1 		$1.41M Buy
9,347
+2,735
+41% +$434K 0.14% 157
2020
Q4 		$1M Buy
+6,612
New +$945K 0.11% 175
2020
Q3 		– Sell
-14,868
Closed -$2.03M – 309
2020
Q2 		$2.03M Buy
14,868
+8,360
+128% +$1.07M 0.28% 86
2020
Q1 		$701 Sell
6,508
-150
-2% -$17.3K 0.02% 185
2019
Q4 		$802K Buy
6,658
+9
+0.1% +$1K 0.14% 159
2019
Q3 		$662K Sell
6,649
-1,480
-18% -$155K 0.12% 168
2019
Q2 		$887K Sell
8,129
-198
-2% -$21.1K 0.18% 121
2019
Q1 		$931K Buy
8,327
+153
+2% +$16.8K 0.2% 108
2018
Q4 		$788K Sell
8,174
-175
-2% -$18.6K 0.2% 119
2018
Q3 		$1.02M Buy
8,349
+173
+2% +$20.4K 0.23% 94
2018
Q2 		$898K Buy
8,176
+1,455
+22% +$156K 0.21% 107
2018
Q1 		$717K Buy
6,721
+83
+1% +$9.2K 0.18% 125
2017
Q4 		$709K Buy
6,638
+197
+3% +$21.1K 0.18% 126
2017
Q3 		$716K Buy
6,441
+108
+2% +$11.5K 0.19% 127
2017
Q2 		$655K Buy
6,333
+72
+1% +$7.09K 0.11% 126
2017
Q1 		$612K Sell
6,261
-384
-6% -$36.8K 0.19% 124
2016
Q4 		$588K Sell
6,645
-6
-0.1% -$546 0.2% 124
2016
Q3 		$642K Sell
6,651
-135
-2% -$12.8K 0.05% 119
2016
Q2 		$582K Buy
+6,786
New +$609K 0.23% 106
2015
Q1 		– Sell
-14,058
Closed -$1.42M – 259
2014
Q4 		$1.42M Sell
14,058
-1,569
-10% -$152K 0.62% 40
2014
Q3 		$1.43M Sell
15,627
-684
-4% -$60K 0.51% 51
2014
Q2 		$1.4M Sell
16,311
-1,380
-8% -$109K 0.43% 59
2014
Q1 		$1.39M Buy
+17,691
New +$1.47M 0.48% 57

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NWAM LLC's IBB Position: Q1 2026 in Review

NWAM LLC reduced its iShares Biotechnology ETF (IBB) stake by 9.5% in Q1 2026, selling an estimated $25.1K and leaving 1,408 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #560.

NWAM LLC first reported a position in IBB in Q1 2014 and has held it in 41 quarters since. The position peaked at $6.67M in Q4 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • NWAM LLC held 1,408 shares of iShares Biotechnology ETF worth $238K as of Q1 2026.
  • NWAM LLC sold 147 iShares Biotechnology ETF shares in Q1 2026, an estimated $25.1K.
  • iShares Biotechnology ETF made up 0.01% of NWAM LLC's portfolio in Q1 2026, its #560 holding.
  • NWAM LLC first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 41 quarters since.
  • NWAM LLC's iShares Biotechnology ETF position peaked at $6.67M in Q4 2022.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.